CME czar goes to Pfizer

Share this article:
Maureen Doyle-Scharff
Maureen Doyle-Scharff
Pfizer, in the midst of revamping its CME department, scored a coup with the recent hiring of Maureen Doyle-Scharff, MBA.

Doyle-Scharff comes from the Ross Products division of Abbott Labs, where for the last two years she directed healthcare education, policy and programs. Her new title at Pfizer is director, medical education, US external medical affairs.

A well-known advocate of CME among all provider groups, Doyle-Scharff holds positions on the boards of several medical education professional groups. Before joining Ross, she was executive director, professional and strategic customer alliances for Johnson & Johnson.

Pfizer's Medical Education Grants department, under the direction of Mike Saxton, MEd, senior director, team leader, is placing more emphasis on the competency of personnel. Earlier this year, the firm made reviewers in the department re-interview for jobs, with candidates required to meet higher standards.

Bringing in someone of high stature, who shares his vision, could put Saxton in a better position to implement his plans, say people familiar with the matter.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.